title: Novel strategies for the management of right ventricular failure with pulmonary hypertension.
abstract: The authors report a case where four novel strategies were successfully used in the management of advanced right ventricular failure with severe pulmonary hypertension and complex adult congenital heart disease. These included combination and optimisation of three advanced therapies for pulmonary hypertension, therapeutic abdominal paracentesis, correction of underlying metabolic/endocrine disturbance and a new inotropic agent.
authors.affiliation: National Pulmonary Hypertension Service, Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton & Harefield NHS Trust, Sydney Street, London, UK.
authors.forename: I C
authors.initials: IC
authors.lastname: Meryon
authors.forename: P
authors.initials: P
authors.lastname: Marino
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001201:Ascites / Q000628:therapy; D002316:Cardiotonic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D018450:Disease Progression; D004359:Drug Therapy, Combination; D004452:Echocardiography; D004562:Electrocardiography; D011464:Epoprostenol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use; D006976:Hypertension, Pulmonary / Q000150:complications* / Q000503:physiopathology / Q000628:therapy*; D019152:Paracentesis / Q000379:methods; D011724:Pyridazines / Q000627:therapeutic use; D000077464:Simendan; D018497:Ventricular Dysfunction, Right / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*
chemical_list: D000900:Anti-Bacterial Agents; D000959:Antihypertensive Agents; D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan; D011464:Epoprostenol